Managing Myeloma
- 2011-01-20 - Just Published in JCO Editorials: Genetic Predisposition for Chemotherapy-Induced Neuropathy in Multiple Myeloma.
- 2011-01-20 - Just Published in JCO: Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma.
- 2011-01-20 - Celgene must give Canada drug data, court rules --Reuters
- 2011-01-19 - Martha Mautner, State Department official Dies of Multiple Myeloma -- Washington Post
- 2011-01-17 - Even cancer can't stop her -- The Recorder & Times / Canada
- 2011-01-14 - MMRF, Synta Pharmaceuticals to develop multiple myeloma drug ganetespib
- 2011-01-14 - One-fifth of survivors reported cancer-related chronic pain- HemeOnc Today
- 2011-01-13 - First Firefighter Dies Since Signing of 9/11 Health Law
- 2011-01-12 - Coles Says Onyx Myeloma Drug May Be on Market in 2012 -- Bloomberg YouTube
- 2011-01-11 - What's up at JPMorgan health conference, so far
- 2011-01-11 - Celgene Cut to Neutral -- Zacks Investment Research
- 2011-01-11 - Senesco Technologies' Lead Therapeutic Candidate SNS01-T Granted Orphan Drug Status From FDA For Treatment Of Multiple Myeloma -- Medical News Today
- 2011-01-06 - Three Boston biotechs win $1M multiple myeloma grants- Boston Business Journal
- 2011-01-05 - Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
- 2011-01-05 - The Leukemia and Lymphoma Society: Retains John Keckhaver Government Relations and Analysis, LLC for Wisconsin lobbying effort